4/22
04:05 pm
flgt
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
Low
Report
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
4/17
03:20 pm
flgt
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
Low
Report
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
4/16
07:30 am
flgt
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026
Low
Report
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026
4/15
04:48 pm
flgt
Cineverse Names Sean McCabe CFO [Yahoo! Finance]
Low
Report
Cineverse Names Sean McCabe CFO [Yahoo! Finance]
4/1
04:10 pm
flgt
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
Low
Report
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
3/25
07:00 pm
flgt
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
Low
Report
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
3/23
06:22 pm
flgt
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
Low
Report
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
3/19
08:00 pm
flgt
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Low
Report
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
3/17
06:00 pm
flgt
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
Low
Report
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
3/17
05:08 pm
flgt
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx [Yahoo! Finance]
Low
Report
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx [Yahoo! Finance]
3/17
04:31 pm
flgt
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
Low
Report
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
3/16
10:23 am
flgt
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
Low
Report
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
3/13
09:00 am
flgt
Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm
Low
Report
Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm
3/12
02:06 pm
flgt
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
Low
Report
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
3/12
10:00 am
flgt
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
3/12
09:23 am
flgt
Fulgent Genetics: A Major Market Misconception [Seeking Alpha]
Low
Report
Fulgent Genetics: A Major Market Misconception [Seeking Alpha]
3/10
04:29 pm
flgt
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
3/5
05:07 pm
flgt
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
3/3
04:34 pm
flgt
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
3/2
01:10 pm
flgt
Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Low
Report
Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
3/1
10:42 am
flgt
A Look At Fulgent Genetics (FLGT) Valuation After 2025 Results And 2026 Revenue Guidance [Yahoo! Finance]
Medium
Report
A Look At Fulgent Genetics (FLGT) Valuation After 2025 Results And 2026 Revenue Guidance [Yahoo! Finance]
2/27
04:34 pm
flgt
Fulgent Genetics Inc (FLGT) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
Medium
Report
Fulgent Genetics Inc (FLGT) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
2/27
12:00 pm
flgt
Fulgent Genetics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Fulgent Genetics Q4 Earnings Call Highlights [Yahoo! Finance]
2/27
07:14 am
flgt
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
2/27
07:00 am
flgt
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
High
Report
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results